Europe PMC

This website requires cookies, and the limited processing of your personal data in order to function. By using the site you are agreeing to this as outlined in our privacy notice and cookie policy.

Hepatic fibrosis. Pathogenesis and principles of therapy.

Author information

Affiliations

  • 1. Division of Liver Diseases, Mount Sinai School of Medicine, New York, New York, USA.
      Authors
    • Albanis E 1
    (1 author)

Clinics in Liver Disease, 01 May 2001, 5(2):315-34, v-vi
https://doi.org/10.1016/s1089-3261(05)70168-9 PMID: 11385966 

Review

Abstract 

There has been great progress made in our understanding of the cellular mechanisms of hepatic fibrosis. The recognition that the hepatic stellate cell, (formerly know as lipocyte, Ito, or fat-storing cell), played a central role in the fibrotic response was key to our understanding. Stellate cells undergo a process known as activation, in response to any insult. Activation is a broad phenotypic response, characterized by distinct functional changes in proliferation, fibrogenesis, contractility, cytokine secretion, and matrix degradation. Insights gained into the molecular regulations of stellate cell activation may lead to new antifibrotic therapies, which may reduce morbidity and mortality in patients with chronic liver injury.

Full text links 

Read article at publisher's site: https://doi.org/10.1016/s1089-3261(05)70168-9

References 

Articles referenced by this article (93)

Show 10 more references (10 of 93)

Citations & impact 

Impact metrics

121
Citations
Jump to Citations

Citations of article over time

Article citations

Go to all (121) article citations

Similar Articles 

To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.